Company Description
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.
It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
| Country | United States |
| Founded | 1995 |
| IPO Date | Oct 1, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 291 |
| CEO | Steven Williamson |
Contact Details
Address: 700 Chesapeake Drive Redwood City, California 94063 United States | |
| Phone | 650 364 0400 |
| Website | pulmonx.com |
Stock Details
| Ticker Symbol | LUNG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $19.00 |
| CIK Code | 0001127537 |
| CUSIP Number | 745848101 |
| ISIN Number | US7458481014 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven S. Williamson | Chief Executive Officer, President and Director |
| Mehul Joshi | Chief Financial Officer |
| David A. Lehman J.D. | General Counsel and Secretary |
| Sri Radhakrishnan | Chief Technical Officer |
| Lauren Cristina | Vice President of Finance and Administration (U.S.) |
| Marcee M. Maroney | Vice President of Marketing |
| Sarah Huber | Vice President of Sales (U.S.) |
| Lisa Paul | Chief People Officer |
| Jérôme Erath | Senior Vice President and GM of Europe Middle-East & Africa |
| Geoffrey Beran Rose | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2025 | SCHEDULE 13G/A | Filing |
| Apr 8, 2025 | ARS | Filing |
| Apr 8, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 20, 2025 | 144 | Filing |
| Mar 3, 2025 | 144 | Filing |
| Feb 25, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 25, 2025 | 10-K | Annual Report |
| Feb 20, 2025 | 144 | Filing |
| Feb 19, 2025 | 8-K | Current Report |